record #210255889265558 | mrbgh | 80689098 | | 8915684 | 6/20/2004 12:00:00 am | atrial fibrillation and romi | | dis | admission date: 7/4/2004 report status:discharge date: 9/22/2004 discharge orders skwarek , jarvis v 939-29-12-3angeles ter riservice: cardischarge patient on: 6/7/04 at 04:00 pmcontingent upon ho evaluationwill d/c order be used as the d/c summary: yesattending: canpos , rafael e. , m.d.code status:full codedisposition: homedischarge medications:tylenol ( acetaminophen ) 650 mg po q4h prn headacheecasa ( aspirin enteric coated ) 81 mg po qdstarting today ( 8/7 )atenolol 50 mg po qdchlordiazepoxide hcl 10 mg po tidenalapril maleate 40 mg po qdoverride notice: override added on 11/23/04 bylandkamer , damian g. , m.d.on order for kcl immediate release po ( ref # 30383744 )potentially serious interaction: enalapril maleate &amp;potassium chloride reason for override: will monitorhydrochlorothiazide 25 mg po qdhold if: sbp&lt;100 and call honitroglycerin 1/150 ( 0.4 mg ) 1 tab sl q5min x 3prn chest pain , other:throat painhold if: sbp&lt;100 and call hoinstructions: take in sitting positiondilantin ( phenytoin ) 200 mg po bidfood/drug interaction instructionif on tube feeds , please cycle ( hold 1 hr before to 2 hrafter )mvi therapeutic ( therapeutic multivitamins ) 1 tab po qdoverride notice: override added on 11/23/04 byboyarsky , erich m. , m.d.on order for simvastatin po ( ref # 65353798 )potentially serious interaction: niacin , vit. b-3 &amp;simvastatin reason for override: will monitorlipitor ( atorvastatin ) 40 mg po qdalert overridden: override added on 6/7/04 by :potentially serious interaction: niacin , vit. b-3 &amp;atorvastatin calcium reason for override: will monitorranitidine hcl 150 mg po bidglyburide 10 mg po bidmetformin 1 , 000 mg po bidcoumadin ( warfarin sodium ) 5 mg po qdinstructions: get blood checked ( inr ) in 3 days for dr.serens to adjust your dosing ( inr goal 2-3 )food/drug interaction instructionno high vitamin-k containing foodsalert overridden: override added on 6/7/04 by :potentially serious interaction: aspirin &amp; warfarinpotentially serious interaction: phenytoin &amp; warfarinpotentially serious interaction: atorvastatin calcium &amp;warfarinpotentially serious interaction: atorvastatin calcium &amp;warfarin reason for override: will monitordiet: house / low chol/low sat. fatdiet: house / ada 2100 cals/dydiet: 2 gram sodiumactivity: walking as toleratedfollow up appointment( s ):dr. kimberly 3 days ,arrange inr to be drawn on 1/3/04 with f/u inr's to be drawn every2 days. inr's will be followed by ny'stan medical center pcpallergy: penicillinsadmit diagnosis:atrial fibrillation and romiprincipal discharge diagnosis ;responsible after study for causing admission )atrial fibrillation and romiother diagnosis;conditions , infections , complications , affecting treatment/staycad ( coronary artery disease ) htn ( hypertension ) chf ( congestiveheart failure ) dm ( diabetesmellitus ) hypercholesterolemia ( elevated cholesterol ) pvd ( peripheralvascular disease ) past smoking ( pastsmoking ) past etoh ( h/o alcohol abuse ) seizures ( seizure )operations and procedures:noneother treatments/procedures ( not in o.r. )adenosine mibi: negative for ischemiabrief resume of hospital course:71 yo man with cad s/p 3vcabg/pci , paf , htn ,niddm , chf ( ef 60% in 1999; diastolic dysfxn ) here with 1-2 wks of doeand throat tightness. originally s/f stress test but found to be inafib w/ rvr ( 120s ) before test. taken to ed wheregiven iv lopressor , asa , iv heparin withimproved symptoms after hr control to 90-100s.pe: afebrile bp 135/72 hr 111--&gt; 96 rr 20 sao2 97% 2l; irreg irregrhythm no m/g/r , jvp 8 cm , ctab , soft belly , no le edema , neg neuroexam labs: neg cardiac enzymes x 1 , cr 0.9 , hct39.5 , wbc 9.37 , inr 1.0; ekg with new twf i , v6 , twil; cxrneg. course: cad with paf now with doe andthroat tightness and re-conversion to afib.1. cv: -ischemia: doubted acs but given signif cad , needed to romi--&gt; resulted in 3 sets of neg cardiac enzymes. adenosine mibirevealed no ischemia- c/w normal study. continued on asa but decreasedto 81mg only , statin , bb: but increased atenolol to 50 mg from 25mgqd , acei , iv heparin.held plavix , iib/iiia. - rhythm: atrial fibrillation on admission butconverted to nsr after rate control with beta blockade. echocardiogramrevealed no dramatic changes from prior studdy in 1999: ef 50-55% withla size in the upper limits , no la thrombus; pasp 35 + rap and isolatedhk in inferior septum ( similar to mild hk seen in mid-septum in 1999 ).tsh was within normal limits and d-dimer was negativesuggesting against pe. rate control was increased with increasedatenolol. pt refused lovenox shots and will be discharged on coumadinfor cva prophylaxis. inr should be followed on 9/10 am by spe healthat rah .  - pump: euvolemic but hx of diastolic dyxfxn.echo was not significantly altered from 1999 as noted above. no diuresis was necessary.2. pulm: suppl o2 and doe was likely cardiac-related. workup as above.3. renal: stable cr4. neuro: dilantin for sz d/o. dilantin level was in therapeuticrange ( 10 ) on admit.5. gi: ranitidine for pud6. psych: chlordiazepoxide per home dosing7. dispo: pt will be discharged in stable condition. he should followup with newthic for inr check on 9/10 days and coumadinadjustment.additional comments: please see dr. plunk in 3 days to check your inr and to adjust yourcoumadin dose accordingly.discharge condition: stableto do/plan:have inr checked on 9/10 am for coumadin adjustment by gardman vero men medical centerclinic ( inr goal 2-3 ).no dictated summaryentered by: geisler , hubert billy , m.d. ( kq1 ) 6/7/04 @ 03:07 pm end of discharge orders [report_end]